- Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. Journal of Cellular and Molecular Medicine. 2004; 8(3):301â16. doi: 10.1111/j.1582-4934.2004.tb00320.x
- Razban V, Lotfi AS, Soleimani M, Ahmadi H, Massumi M, Khajeh S, et al. HIF-1α overexpression induces angiogenesis in mesenchymal stem cells. BioResearch Open Access. 2012; 1(4):174â83. doi: 10.1089/biores.2012.9905
- Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: An update. Cell Transplantation. 2016; 25(5):829â48. doi: 10.3727/096368915x689622
- Razban V, Khajeh S, Lotfi AS, Mohsenifar A, Soleimani M, Khoshdel A, et al. Engineered heparan sulfate-collagen IV surfaces improve human mesenchymal stem cells differentiation to functional hepatocyte-like cells. Journal of Biomaterials and Tissue Engineering. 2014; 4(10):811â22. doi: 10.1166/jbt.2014.1234
- Sahebghadam Lotfi A. High yield generation of hepatocyte like cells from adipose derived stem cells. Scientific Research and Essays. 2012; 7(10):1141-7. doi: 10.5897/sre11.1437
- Keating A. Mesenchymal stromal cells. Current Opinion in Hematology. 2006; 13(6):419â25. doi: 10.1097/01.moh.0000245697.54887.6f
- Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F., Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315â7. doi: 10.1080/14653240600855905
- Khairoun M, S Korevaar S. Human bone marrow- and adipose tissue-derived mesenchymal stromal cells are immunosuppressive in vitro and in a humanized allograft rejection model. Journal of Stem Cell Research & Therapy. 2013; doi: 10.4172/2157-7633.s6-001
- Denu RA, Hematti P. Effects of oxidative stress on mesenchymal stem cell biology. Oxidative Medicine and Cellular Longevity. 2016; 2016:1â9. doi: 10.1155/2016/2989076
- Gstraunthaler G. Alternatives to the use of fetal bovine serum: Serum-free cell culture. Altex. 2003; 20(4):275-81. PMID: 14671707
- Fernandes-Platzgummer A, Carmelo JG, da Silva CL, Cabral JMS. Clinical-grade manufacturing of therapeutic human mesenchymal stem/stromal cells in microcarrier-based culture systems. Methods in Molecular Biology. 2016; 375â88. doi: 10.1007/978-1-4939-3584-0_22
- Bieback K, Hecker A, Kocaömer A, Lannert H, Schallmoser K, Strunk D, et al. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells. 2009; 27(9):2331â41. doi: 10.1002/stem.139
- Brunner D, Frank J, Appl H, Schöffl H, Pfaller W, Gstraunthaler G. Serum-free cell culture: The serum-free media interactive online database. Altex. 2010; 27(1):53-62. PMID: 20390239
- Van der Valk J, Brunner D, De Smet K, Fex Svenningsen Ã
, Honegger P, Knudsen LE, et al. Optimization of chemically defined cell culture media â Replacing fetal bovine serum in mammalian in vitro methods. Toxicology in Vitro. 2010; 24(4):1053â63. doi: 10.1016/j.tiv.2010.03.016
- Taupin P. Derivation of embryonic stem cells for cellular therapy: Challenges and new strategies. Medical Science Monitor. 2006; 12(4):75-8.
- Kobayashi T. Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serum. Journal of Bone and Joint Surgery - British Volume. 2005; 87(10):1426â33. doi: 10.1302/0301-620x.87b10.16160
- Wang Z, Zhang F, Wang L, Yao Y, Zhao Q, Gao X. Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via toll-like receptor (TLR)-4 and PI3K/Akt. Cell Biology International. 2009; 33(6):665â74. doi: 10.1016/j.cellbi.2009.03.006
- Wang X, Zhao T, Huang W, Wang T, Qian J, Xu M, et al. Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells. 2009; 27(12):3021-31. doi: 10.1002/stem.230.
- Findeisen HM, Pearson KJ, Gizard F, Zhao Y, Qing H, Jones KL, et al. Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis. PLoS ONE. 2011; 6(4):18532. doi: 10.1371/journal.pone.0018532
- Altaner C, Altanerova V, Cihova M, Ondicova K, Rychly B, Baciak L, et al. Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario. International Journal of Cancer. 2013; 134(6):1458â65. doi: 10.1002/ijc.28455
- Cucchiarini M, Venkatesan JK, Ekici M, Schmitt G, Madry H. Human mesenchymal stem cells overexpressing therapeutic genes: From basic science to clinical applications for articular cartilage repair. Bio-Medical Materials and Engineering. 2012; 22(4):197-208.
- KeyÃer G, Müller L, Schendel M, Schmoll H-J. [Therapeutic use of mesenchymal stromal cells in autoimmune diseases (German)]. Zeitschrift für Rheumatologie. 2009; 68(3):220â7. doi: 10.1007/s00393-008-0394-2
- Seo JH, Cho S-R. Neurorestoration induced by mesenchymal stem cells: Potential therapeutic mechanisms for clinical trials. Yonsei Medical Journal. 2012; 53(6):1059. doi: 10.3349/ymj.2012.53.6.1059
- Valle-Prieto A, Conget PA. Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells and Development. 2010; 19(12):1885â93. doi: 10.1089/scd.2010.0093
|